ClinicalTrials HQ

Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

Active, not recruiting · NCT05143229 · Registry updated 2026-05-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast CancerNeoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 12026-05-01NCT05143229

3 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Gilead Sciences180
Novartis Pharmaceuticals432
University of Kansas Medical Center169

7 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
The University of Kansas Cancer CenterWestwoodUnited States31
The University of Kansas Cancer Center - Indian CreekOverland ParkUnited States2
The University of Kansas Cancer Center - Lee's SummitLee's SummitUnited States6
The University of Kansas Cancer Center - NorthKansas CityUnited States4
The University of Kansas Cancer Center - North Kansas City HospitalKansas CityUnited States1
The University of Kansas Cancer Center - Overland ParkOverland ParkUnited States6
The University of Kansas Clinical Research CenterFairwayUnited States9